2012•Unpublished venueRequires access

Lower Nephrotoxicity, Adverse Effects And Hospital Length Of Stay With Exclusive Lipid Formulations Of Amphotericin B Vs. Amphotericin B Deoxycholate Followed By Lipid Formulation Amphotericin B

Paresh Chaudhari, Rolin L. Wade, Jaime L. Natoli, Robert J. Taylor, Brian Harris Nathanson, David B. Horn

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Amphotericin B, Nephrotoxicity, Amphotericin B deoxycholate, Adverse effect, Pharmacology, Medicine, Chemistry, Antifungal

Back to paper search Browse research topics Original source

Lower Nephrotoxicity, Adverse Effects And Hospital Length Of Stay With Exclusive Lipid Formulations Of Amphotericin B Vs. Amphotericin B Deoxycholate Followed By Lipid Formulation Amphotericin B — Research Paper | ScholarLens